Effect of Natriuretic Peptide-Guided Therapy on Outcomes in High-Risk Patients with Heart Failure and Reduced Ejection Fraction: A Randomized Clinical Trial

被引：1
|
作者：
Felker, G. Michael [1 ]
Anstrom, Kevin J. [1 ]
Adams, Kirkwood F. [2 ]
Ezekowitz, Justin A. [3 ]
Fiuzat, Mona [1 ]
Houston-Miller, Nancy [4 ]
Januzzi, James L., Jr. [5 ]
Mark, Daniel B. [1 ]
Pina, Ileana L. [6 ]
Passmore, Gayle [1 ]
Whellan, David J. [7 ]
Yang, Hongqiu [1 ]
Cooper, Lawton S. [8 ]
Leifer, Eric S. [8 ]
Desvigne-Nickens, Patrice [8 ]
O'Connor, Christopher M. [1 ,9 ]
机构：
[1] Duke Clin Res Inst, Durham, NC USA
[2] Univ N Carolina, Chapel Hill, NC USA
[3] Univ Alberta, Canadian VIGOUR Ctr, Edmonton, AB, Canada
[4] LifeCare Co, Menlo Pk, CA USA
[5] Massachusetts Gen Hosp, Cardiol Div, Boston, MA 02114 USA
[6] Albert Einstein Coll Med, Bronx, NY 10467 USA
[7] Thomas Jefferson Univ, Philadelphia, PA 19107 USA
[8] NHLBI, Div Cardiovasc Sci, Bldg 10, Bethesda, MD 20892 USA
[9] Inova Heart & Vasc Ctr, Fairfax, VA USA
来源：
JOURNAL OF CARDIAC FAILURE | 2017年 / 23卷 / 11期
关键词：
D O I：
10.1016/j.cardfail.2017.10.004
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：830 / 830
页数：1
相关论文
共 50 条
  • [41] Outcomes of TAVI in patients with heart failure with reduced ejection fraction
    Sener, Y. Z. Yusuf Ziya
    Keresteci, A. H.
    Ates, A. H.
    Sahiner, M. L.
    Kaya, E. B.
    Aytemir, K.
    EUROPEAN JOURNAL OF HEART FAILURE, 2023, 25 : 353 - 353
  • [42] Dapagliflozin and Kidney Outcomes in Patients With Heart Failure With Mildly Reduced or Preserved Ejection Fraction A Prespecified Analysis of the DELIVER Randomized Clinical Trial
    Mc Causland, Finnian R.
    Claggett, Brian L.
    Vaduganathan, Muthiah
    Desai, Akshay S.
    Jhund, Pardeep
    de Boer, Rudolf A.
    Docherty, Kieran
    Fang, James
    Hernandez, Adrian F.
    Inzucchi, Silvio E.
    Kosiborod, Mikhail N.
    Lam, Carolyn S. P.
    Martinez, Felipe
    Saraiva, Jose F. Kerr
    McGrath, Martina M.
    Shah, Sanjiv J.
    Verma, Subodh
    Langkilde, Anna Maria
    Petersson, Magnus
    McMurray, John J., V
    Solomon, Scott D.
    JAMA CARDIOLOGY, 2023, 8 (01) : 56 - 65
  • [43] Multimorbidity and outcomes in patients with heart failure and reduced ejection fraction
    Gannuscio, J. Jacqueline
    Tomer, M.
    Valentova, M.
    Fonarow, G.
    Kanonidis, I.
    Adamopoulos, C.
    Deedwania, P.
    Aronow, W.
    Anker, S.
    Ahmed, A.
    EUROPEAN JOURNAL OF HEART FAILURE, 2016, 18 : 321 - 321
  • [44] Empagliflozin in Non-diabetic Heart Failure Patients With Reduced Ejection Fraction - The Empatropism Randomized Clinical Trial
    Santos-Gallego, Carlos G.
    Vargas-Delgado, Ariana P.
    Requena-Ibanez, Juan Antonio
    Garcia-Ropero, Alvaro
    Mancini, Donna
    Pinney, Sean
    Atallah-Lajam, Farah
    Contreras, Johanna P.
    Macaluso, Frank
    Sartori, Samantha
    Roque, Merce
    Fergus, Icilma
    Sabatel-Perez, Fernando
    Rodriguez-Cordero, Anderly
    Zafar, Urooj
    Moreno, Pedro R.
    Abascal, Vivian M.
    Lala, Anu
    Tamler, Ronald
    Sanz, Javier
    Fuster, Valentin
    Badimon, Juan J.
    CIRCULATION, 2020, 142 (24) : E484 - E484
  • [45] Cost-Effectiveness of Vericiguat in Patients With Heart Failure With Reduced Ejection Fraction: The VICTORIA Randomized Clinical Trial
    Chew, Derek S.
    Li, Yanhong
    Bigelow, Robert
    Cowper, Patricia A.
    Anstrom, Kevin J.
    Daniels, Melanie R.
    Davidson-Ray, Linda
    Hernandez, Adrian F.
    O'Connor, Christopher M.
    Armstrong, Paul W.
    Mark, Daniel B.
    CIRCULATION, 2023, 148 (14) : 1087 - 1098
  • [46] EJECTION FRACTION, BIOMARKERS, AND OUTCOMES IN HEART FAILURE WITH REDUCED EJECTION FRACTION AND THE IMPACT OF VERICIGUAT ON OUTCOMES IN THE VICTORIA TRIAL
    Butler, Javed
    Zheng, Yinggan
    Bonderman, Diana
    Lund, Lars
    DeFilippi, Christopher R.
    Blaustein, Robert
    Ezekowitz, Justin A.
    Freitas, Cecilia
    Hernandez, Adrian F.
    O'Connor, Christopher M.
    Voors, Adriaan
    Westerhout, Cynthia M.
    Lam, Carolyn S. P.
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2022, 79 (09) : 372 - 372
  • [47] Relationship of ejection fraction and natriuretic peptide trajectories in heart failure with baseline reduced and mid-range ejection fraction
    Bilchick, Kenneth C.
    Stafford, Patrick
    Laja, Olusola
    Elumogo, Comfort
    Bediako, Persey
    Tolbert, Nora
    Sawch, Douglas
    David, Sthuthi
    Sodhi, Nishtha
    Barber, Anita
    Kwon, Younghoon
    Mehta, Nishaki
    Patterson, Brandy
    Breathett, Khadijah
    Mazimba, Sula
    AMERICAN HEART JOURNAL, 2022, 243 : 1 - 10
  • [48] Representation of black patients in randomized clinical trials of heart failure with reduced ejection fraction
    Sullivan, Lonnie T., II
    Randolph, Tiffany
    Merrill, Peter
    Jackson, Larry R.
    Egwim, Chidiebube
    Starks, Monique A.
    Thomas, Kevin L.
    AMERICAN HEART JOURNAL, 2018, 197 : 43 - 52
  • [49] N-terminal pro brain natriuretic peptide-guided management in patients with heart failure and preserved ejection fraction: findings from the Trial of Intensified versus standard Medical therapy in Elderly patients with Congestive Heart Failure (TIME-CHF)
    Maeder, Micha T.
    Rickenbacher, Peter
    Rickli, Hans
    Abbuehl, Heidi
    Gutmann, Marc
    Erne, Paul
    Vuilliomenet, Andre
    Peter, Martin
    Pfisterer, Matthias
    Brunner-La Rocca, Hans-Peter
    EUROPEAN JOURNAL OF HEART FAILURE, 2013, 15 (10) : 1148 - 1156
  • [50] B-Type Natriuretic Peptide-Guided Heart Failure Therapy A Meta-analysis
    Porapakkham, Pramote
    Porapakkham, Pornwalee
    Zimmet, Hendrik
    Billah, Baki
    Krum, Henry
    ARCHIVES OF INTERNAL MEDICINE, 2010, 170 (06) : 507 - 514
12345